title: Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.
abstract: The aim of this study was to compare the frequency of upper gastrointestinal (GI) complaints and complications between chronic rheumatic patients who are most often non-steroidal anti-inflammatory drugs (NSAIDs) users and patients with other chronic conditions. In this comparison we took into account known risk factors for upper GI disease. To achieve the study aims we performed a combined cross-sectional and retrospective study. We therefore interviewed by means of a standard questionnaire, an index and a reference group, about current upper GI complaints and previous complications. The former group comprises 578 outpatients of the Department of Rheumatology, the latter of 531 outpatients of the Departments of Internal Medicine, Pulmonology, and Cardiology. Although the number of patients in the index group being chronically treated with NSAIDs was very high (62% versus 9% in the reference group: P < 0.00001), no between-group differences were found for the frequency of several current upper gastrointestinal complaints or for the number of upper gastrointestinal investigations ever performed (35% and 37%: NS) or for the use of gastric drugs (14% and 10%: NS). Risk factors for upper GI complaints were not related to NSAID use but with the use of prednisolone, history of duodenal ulcer disease, family history of peptic ulcer disease and female sex. For peptic ulcer disease, bleeding, and gastric surgery, the only difference between the index and reference groups concerned the frequency of gastric ulcers (6.7% and 2.8%: P < 0.005), which was highest in patients with rheumatoid arthritis. Upper GI bleeding had more often been present in male seropositive rheumatoid arthritis patients (13.2% [corrected] and 4.5%: P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Departments of Rheumatology, University Hospital, Leiden, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Janssen
authors.forename: B A
authors.initials: BA
authors.lastname: Dijkmans
authors.forename: F A
authors.initials: FA
authors.lastname: van der Sluys
authors.forename: J G
authors.initials: JG
authors.lastname: van der Wielen
authors.forename: K
authors.initials: K
authors.lastname: Havenga
authors.forename: J P
authors.initials: JP
authors.lastname: Vandenbroucke
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
authors.forename: A H
authors.initials: AH
authors.lastname: Zwinderman
authors.forename: A
authors.initials: A
authors.lastname: Cats
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D014456:Ulcer / Q000150:complications
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal